Skip to main content
Top
Published in: BMC Infectious Diseases 1/2022

Open Access 01-12-2022 | Whooping Cough | Research

Risk factors and prediction model of severe pertussis in infants < 12 months of age in Tianjin, China

Authors: Cui Zhang, Yanmei Zong, Zhe Wang, Li Wang, Ying Li, Yuejie Yang

Published in: BMC Infectious Diseases | Issue 1/2022

Login to get access

Abstract

Background

To identify risk factors associated with the prognosis of pertussis in infants (< 12 months).

Methods

A retrospective study on infants hospitalized with pertussis January 2017 to June 2019. The infants were divided into two groups according to the severity of disease: severe pertussis and non-severe pertussis groups. We collected all case data from medical records including socio-demographics, clinical manifestations, and auxiliary examinations. Univariate analysis and Logistic regression were used.

Results

Finally, a total of 84 infants with severe pertussis and 586 infants with non-severe pertussis were admitted. The data of 75% of the cases (severe pertussis group, n = 63; non-severe pertussis group, n = 189) were randomly selected for univariate and multivariate logistic regression analysis. The results showed rural area [P = 0.002, OR = 6.831, 95% CI (2.013–23.175)], hospital stay (days) [P = 0.002, OR = 1.304, 95% CI (1.107–1.536)], fever [P = 0.040, OR = 2.965, 95% CI (1.050–8.375)], cyanosis [P = 0.008, OR = 3.799, 95% CI (1.419–10.174)], pulmonary rales [P = 0.021, OR = 4.022, 95% CI (1.228–13.168)], breathing heavily [P = 0.001, OR = 58.811, 95% CI (5.503–628.507)] and abnormal liver function [P < 0.001, OR = 9.164, 95% CI (2.840–29.565)] were independent risk factors, and higher birth weight [P = 0.006, OR = 0.380, 95% CI (0.191–0.755)] was protective factor for severe pertussis in infants. The sensitivity and specificity of logistic regression model for remaining 25% data of severe group and common group were 76.2% and 81.0%, respectively, and the consistency rate was 79.8%.

Conclusions

The findings indicated risk factor prediction models may be useful for the early identification of severe pertussis in infants.
Literature
1.
go back to reference Nguyen VTN, Simon L. Pertussis: the whooping cough. Prim Care. 2018;45(3):423–31.CrossRef Nguyen VTN, Simon L. Pertussis: the whooping cough. Prim Care. 2018;45(3):423–31.CrossRef
2.
3.
go back to reference Vodzak J, Queenan AM, Souder E, Evangelista AT, Long SS. Clinical manifestations and molecular characterization of pertactin-deficient and pertactin-producing bordetella pertussis in children, Philadelphia 2007–2014. Clin Infect Dis. 2017;64(1):60–6.CrossRef Vodzak J, Queenan AM, Souder E, Evangelista AT, Long SS. Clinical manifestations and molecular characterization of pertactin-deficient and pertactin-producing bordetella pertussis in children, Philadelphia 2007–2014. Clin Infect Dis. 2017;64(1):60–6.CrossRef
4.
go back to reference Yeung KHT, Duclos P, Nelson EAS, Hutubessy RCW. An update of the global burden of pertussis in children younger than 5 years: a modelling study. Lancet Infect Dis. 2017;17(9):974–80.CrossRef Yeung KHT, Duclos P, Nelson EAS, Hutubessy RCW. An update of the global burden of pertussis in children younger than 5 years: a modelling study. Lancet Infect Dis. 2017;17(9):974–80.CrossRef
5.
go back to reference von Konig CH, Halperin S, Riffelmann M, Guiso N. Pertussis of adults and infants. Lancet Infect Dis. 2002;2(12):744–50.CrossRef von Konig CH, Halperin S, Riffelmann M, Guiso N. Pertussis of adults and infants. Lancet Infect Dis. 2002;2(12):744–50.CrossRef
6.
go back to reference Kilgore PE, Salim AM, Zervos MJ, Schmitt HJ. Pertussis: microbiology, disease, treatment, and prevention. Clin Microbiol Rev. 2016;29(3):449–86.CrossRef Kilgore PE, Salim AM, Zervos MJ, Schmitt HJ. Pertussis: microbiology, disease, treatment, and prevention. Clin Microbiol Rev. 2016;29(3):449–86.CrossRef
7.
go back to reference Guiso N, Wirsing vin Konig CH. Surveillance of pertussis: methods and implementation. Expert Rev Anti Infect Ther. 2016;14(7):657–67.CrossRef Guiso N, Wirsing vin Konig CH. Surveillance of pertussis: methods and implementation. Expert Rev Anti Infect Ther. 2016;14(7):657–67.CrossRef
8.
go back to reference Hartzell JD, Blaylock JM. Whooping cough in 2014 and beyond: an update and review. Chest. 2014;146(1):205–14.CrossRef Hartzell JD, Blaylock JM. Whooping cough in 2014 and beyond: an update and review. Chest. 2014;146(1):205–14.CrossRef
10.
go back to reference Cherry JD. The prevention of severe pertussis and pertussis deaths in young infants. Expert Rev Vaccines. 2019;18(3):205–8.CrossRef Cherry JD. The prevention of severe pertussis and pertussis deaths in young infants. Expert Rev Vaccines. 2019;18(3):205–8.CrossRef
11.
go back to reference Xu Y, Xu E, Liu S, Zheng W, Zhang X, Du J, Zhang X, Wang J, Che X, Gu W, et al. Seroepidemiology of pertussis in Hangzhou, China, during 2009–2017. Hum Vaccin Immunother. 2019;15(11):2564–70.CrossRef Xu Y, Xu E, Liu S, Zheng W, Zhang X, Du J, Zhang X, Wang J, Che X, Gu W, et al. Seroepidemiology of pertussis in Hangzhou, China, during 2009–2017. Hum Vaccin Immunother. 2019;15(11):2564–70.CrossRef
12.
go back to reference Su QR, Deng JK. Children’s pertussis immunization strategy in China. Zhonghua er ke za zhi Chin J Pediatr. 2020;58(7):615–7. Su QR, Deng JK. Children’s pertussis immunization strategy in China. Zhonghua er ke za zhi Chin J Pediatr. 2020;58(7):615–7.
13.
go back to reference Jiang F, Shen T, Zhang D, Liu C, Liu M, Zhang L, Ye X, Li K. Epidemiological characteristics of pertussis in Guizhou province, 2014–2016. Chin J Vaccines Immun. 2018;024(003):268–73. Jiang F, Shen T, Zhang D, Liu C, Liu M, Zhang L, Ye X, Li K. Epidemiological characteristics of pertussis in Guizhou province, 2014–2016. Chin J Vaccines Immun. 2018;024(003):268–73.
14.
go back to reference Wang C, Zhang H, Zhang Y, Xu L, Miao M, Yang H, Liu Y, He S, Pang L. Analysis of clinical characteristics of severe pertussis in infants and children: a retrospective study. BMC Pediatr. 2021;21(1):65.CrossRef Wang C, Zhang H, Zhang Y, Xu L, Miao M, Yang H, Liu Y, He S, Pang L. Analysis of clinical characteristics of severe pertussis in infants and children: a retrospective study. BMC Pediatr. 2021;21(1):65.CrossRef
15.
go back to reference Subspecialty Group of Infectious Diseases tSoPCMA. Editorial Board CJoP: Recommendation for diagnosis and treatment of Chinese children with pertussis. Zhonghua er ke za zhi Chin J Pediatr. 2017;55(8):568–72. Subspecialty Group of Infectious Diseases tSoPCMA. Editorial Board CJoP: Recommendation for diagnosis and treatment of Chinese children with pertussis. Zhonghua er ke za zhi Chin J Pediatr. 2017;55(8):568–72.
16.
go back to reference Tan TQ, Gerbie MV. Pertussis, a disease whose time has come: what can be done to control the problem? Obstet Gynecol. 2013;122(2 Pt 1):370–3.CrossRef Tan TQ, Gerbie MV. Pertussis, a disease whose time has come: what can be done to control the problem? Obstet Gynecol. 2013;122(2 Pt 1):370–3.CrossRef
17.
go back to reference Namachivayam P, Shimizu K, Butt W. Pertussis: severe clinical presentation in pediatric intensive care and its relation to outcome. Pediatr Crit Care Med. 2007;8(3):207–11.CrossRef Namachivayam P, Shimizu K, Butt W. Pertussis: severe clinical presentation in pediatric intensive care and its relation to outcome. Pediatr Crit Care Med. 2007;8(3):207–11.CrossRef
18.
go back to reference Tan T, Dalby T, Forsyth K, Halperin SA, Heininger U, Hozbor D, Plotkin S, Ulloa-Gutierrez R, Wirsing von Konig CH. Pertussis across the globe: recent epidemiologic trends from 2000 to 2013. Pediatr Infect Dis J. 2015;34(9):e222-232.CrossRef Tan T, Dalby T, Forsyth K, Halperin SA, Heininger U, Hozbor D, Plotkin S, Ulloa-Gutierrez R, Wirsing von Konig CH. Pertussis across the globe: recent epidemiologic trends from 2000 to 2013. Pediatr Infect Dis J. 2015;34(9):e222-232.CrossRef
19.
go back to reference Pillsbury A, Quinn HE, McIntyre PB. Australian vaccine preventable disease epidemiological review series: pertussis, 2006–2012. Commun Dis Intell Q Rep. 2014;38(3):E179-194.PubMed Pillsbury A, Quinn HE, McIntyre PB. Australian vaccine preventable disease epidemiological review series: pertussis, 2006–2012. Commun Dis Intell Q Rep. 2014;38(3):E179-194.PubMed
20.
go back to reference Cao JY, Pan JH. Progress in etiology, pathogenesis and clinical characteristics of pertussis syndrome. Zhonghua er ke za zhi Chin J Pediatr. 2020;58(2):158–61. Cao JY, Pan JH. Progress in etiology, pathogenesis and clinical characteristics of pertussis syndrome. Zhonghua er ke za zhi Chin J Pediatr. 2020;58(2):158–61.
21.
go back to reference Heininger U, Weibel D, Richard JL. Prospective nationwide surveillance of hospitalizations due to pertussis in children, 2006–2010. Pediatr Infect Dis J. 2014;33(2):147–51.CrossRef Heininger U, Weibel D, Richard JL. Prospective nationwide surveillance of hospitalizations due to pertussis in children, 2006–2010. Pediatr Infect Dis J. 2014;33(2):147–51.CrossRef
22.
go back to reference Straney L, Schibler A, Ganeshalingham A, Alexander J, Festa M, Slater A, MacLaren G, Schlapbach LJ, Australian, New Zealand Intensive Care Society Centre for O et al. Burden and outcomes of severe pertussis infection in critically ill infants. Pediatr Crit Care Med. 2016; 17(8):735–742. Straney L, Schibler A, Ganeshalingham A, Alexander J, Festa M, Slater A, MacLaren G, Schlapbach LJ, Australian, New Zealand Intensive Care Society Centre for O et al. Burden and outcomes of severe pertussis infection in critically ill infants. Pediatr Crit Care Med. 2016; 17(8):735–742.
23.
go back to reference Liu C, Yang L, Cheng Y, Xu H, Xu F. Risk factors associated with death in infants <120 days old with severe pertussis: a case-control study. BMC Infect Dis. 2020;20(1):852.CrossRef Liu C, Yang L, Cheng Y, Xu H, Xu F. Risk factors associated with death in infants <120 days old with severe pertussis: a case-control study. BMC Infect Dis. 2020;20(1):852.CrossRef
24.
go back to reference Winter K, Zipprich J, Harriman K, Murray EL, Gornbein J, Hammer SJ, Yeganeh N, Adachi K, Cherry JD. Risk factors associated with infant deaths from pertussis: a case-control study. Clin Infect Dis. 2015;61(7):1099–106.CrossRef Winter K, Zipprich J, Harriman K, Murray EL, Gornbein J, Hammer SJ, Yeganeh N, Adachi K, Cherry JD. Risk factors associated with infant deaths from pertussis: a case-control study. Clin Infect Dis. 2015;61(7):1099–106.CrossRef
25.
go back to reference Hawken S, Ducharme R, Fell DB, Oron AP, Wilson K. Effects of sex and birth weight on non-specific health services use following whole-cell pertussis vaccination: a self-controlled case series analysis. Hum Vaccin Immunother. 2019;15(10):2399–404.CrossRef Hawken S, Ducharme R, Fell DB, Oron AP, Wilson K. Effects of sex and birth weight on non-specific health services use following whole-cell pertussis vaccination: a self-controlled case series analysis. Hum Vaccin Immunother. 2019;15(10):2399–404.CrossRef
26.
go back to reference Langkamp DL, Davis JP. Increased risk of reported pertussis and hospitalization associated with pertussis in low birth weight children. J Pediatr. 1996;128(5 Pt 1):654–9.CrossRef Langkamp DL, Davis JP. Increased risk of reported pertussis and hospitalization associated with pertussis in low birth weight children. J Pediatr. 1996;128(5 Pt 1):654–9.CrossRef
Metadata
Title
Risk factors and prediction model of severe pertussis in infants < 12 months of age in Tianjin, China
Authors
Cui Zhang
Yanmei Zong
Zhe Wang
Li Wang
Ying Li
Yuejie Yang
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2022
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-021-07001-x

Other articles of this Issue 1/2022

BMC Infectious Diseases 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.